Agios sells cancer drug royalty, raising $132M to fund rare disease mission

Agios sells cancer drug royalty, raising $132M to fund rare disease mission

Source: 
MedCity News
snippet: 

Agios Pharmaceuticals sold royalties to an approved cancer drug to get immediate cash to support its new focus on rare diseases. Earlier this year, the FDA approved the biotech’s first rare disease drug, a treatment for a type of anemia.